Giulia Gioiello

Dr. Giulia Gioiello

Department of Medical Sciences - University of Turin, Turin, Piedmont, Italy
orcid
Department of Medical Sciences, University of Turin

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MTMartina Tetti
Martina Tetti
Jacopo BurrelloJacopo Burrello
Jacopo Burrello
JGJessica Goi
Jessica Goi
Mirko Parasiliti-CaprinoMirko Parasiliti-Caprino
Mirko Parasiliti-Caprino
Giulia GioielloGiulia Gioiello
Giulia Gioiello
GMGiulio Mengozzi
Giulio Mengozzi
Primary aldosteronism (PA) is the most common cause of endocrine arterial hypertension, and the suggested screening test for case detection is the aldosterone-to-renin ratio (ARR) or aldosterone-to-direct renin ratio (ADRR) based on radio-immunoassay (RIA) and chemiluminescence assay (CLIA), respectively. The objective of our study was to evaluate the reliability of CLIA for aldosterone and renin measurement and the diagnostic performance of ADRR. A prospective cohort of 1110 patients referred to a single laboratory medicine center underwent measurement of aldosterone and direct renin concentration (DRC) by CLIA and measurement of aldosterone and plasma renin activity (PRA) by RIA. Of 1110 patients, 640 obtained a final diagnosis of hypertension, and 90 of these patients were diagnosed with PA. Overall, between-method correlation was highly significant for aldosterone concentrations (R = 0.945, p < 0.001) and less strong but significant for DRC/PRA (R = 0.422, p < 0.001). Among hypertensive patients, in PA cases, the areas under the receiver operator characteristics (ROC) curves were 0.928 (95% confidence interval 0.904–0.954) for ADRR and 0.943 (95% confidence interval 0.920–0.966) for ARR and were comparable and not significantly different. The highest accuracy was obtained with an ADRR cut-off of 25 (ng/L)/(mIU/L), displaying a sensitivity of 91% and a specificity of 85%. The chemiluminescence assay for aldosterone and DRC is a reliable method for PA diagnosis compared to the classical RIA method.

26 January 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
FRFausto Roveta
Fausto Roveta
ERElisa Rubino
Elisa Rubino
AMAndrea Marcinnò
Andrea Marcinnò
AGAlberto Grassini
Alberto Grassini
EPElisa Maria Piella
Elisa Maria Piella
IRInnocenzo Rainero
Innocenzo Rainero
This study evaluated the diagnostic performance of plasma biomarkers for Alzheimer's disease (AD) using an automated platform. In a cohort of 74 consecutive patients, plasma p-Tau181 levels were significantly higher in AD compared to non-AD groups and showed correlation with cerebrospinal fluid biomarkers. Plasma p-Tau181 demonstrated high diagnostic accuracy for AD, with an area under the curve of 0.854. The findings suggest that plasma biomarkers, particularly p-Tau181, could improve the accessibility and efficiency of AD diagnostics in clinical settings, offering a less invasive and cost-effective alternative to traditional methods.

9 April 2026 in Cells
Verified
Journal Article
Open access
PDF file
CECECCOTTI ELENA
CECCOTTI ELENA
VDVeronica Dimuccio
Veronica Dimuccio
CPChiara Pasquino
Chiara Pasquino
MCMassimo Cedrino
Massimo Cedrino
Maria Beatriz Herrera-SanchezMaria Beatriz Herrera-Sanchez
Maria Beatriz Herrera-Sanchez
SBStefania Bruno
Stefania Bruno
Human liver stem cells (HLSCs) are a mesenchymal stromal cell (MSC)-like population isolated from adult liver biopsies. HLSCs share key characteristics with MSCs, including phenotype and differentiation capabilities. Previous studies have demonstrated that HLSCs promote regeneration in different experimental models of acute and chronic tissue injury and that HLSC-derived extracellular vesicles (HLSC-EVs) recapitulate the therapeutic effects of the cells of origin. This study aimed to determine whether HLSC-EVs, obtained and characterized under good manufacturing practice (GMP) conditions, can influence the progression of liver fibrosis in vivo. The EV production process was carried out under GMP conditions to generate batches of HLSC-EVs by tangential flow filtration. To assess their therapeutic potential, an in vivo model of hepatic fibrosis was established through administration of thioacetamide (TAA). In TAA-treated mice, EV administrations attenuated fibrosis progression. Molecular analyses showed a significant reduction in the expression levels of key pro-fibrotic genes. At the functional level, EV administration resulted in a significant reduction in plasma alanine aminotransferase levels and an increase in albumin levels, indicating improved liver function. These data indicate that HLSC-EVs, produced under GMP conditions, display antifibrotic effects in a chronic liver disease model, leading to improved liver function and histology.

3 September 2026 in Laboratories
Verified
Journal Article
Open access
PDF file
Giulia GioielloGiulia Gioiello
Giulia Gioiello
SLSelene Limoncelli
Selene Limoncelli
MCMaria Crobu
Maria Crobu
PCPaola Caropreso
Paola Caropreso
GMGiulio Mengozzi
Giulio Mengozzi
Introduction: Immunoglobulin M (IgM) paraproteins may interfere with enzymatic creatinine assays, potentially affecting renal function assessment. Reflex IgM testing has been proposed to detect such interference, but its impact on laboratory workflow remains insufficiently characterized. Material and Methods: This retrospective observational study combined two complementary datasets: (1) a clinical cohort of patients evaluated for suspected IgM-related interference over a 7-month period, and (2) a two-month and half representative operational analysis assessing testing volume and turnaround time (TAT) in a high-throughput clinical laboratory. An automated LIS rule triggered IgM testing when creatinine was ≥177 μmol/L. Samples with IgM ≥ 2.5 g/L underwent polyethylene glycol (PEG) precipitation to evaluate potential interference. Test volume and TAT were compared between creatinine-only and reflex workflows. Results: During the 2.5-month operational analysis, 102,849 creatinine measurements were performed, of which 7740 (7.5%) triggered reflex IgM testing, generating 11,091 IgM determinations, 56.5% of which were reflex-driven. During the full seven-month clinical observation period, clinically relevant IgM-related interference was confirmed in 8 patients. Reflex workflows were associated with increased TAT compared with creatinine-only testing. Conclusions: Universal reflex IgM testing improves detection of rare analytical interference but generates substantial workload and increases TAT. During the 2.5-month operational analysis period, only 2 of 7740 reflex-triggered samples (0.026%) resulted in confirmed clinically relevant interference. A selective, risk-based strategy may therefore represent a more efficient and sustainable approach to routine laboratory practice.

24 August 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SBSilvia Boschi
Silvia Boschi
ACALBERTO MARIO CHIARANDON
ALBERTO MARIO CHIARANDON
ACAurora Cermelli
Aurora Cermelli
CLChiara Lombardo
Chiara Lombardo
Giulia GioielloGiulia Gioiello
Giulia Gioiello
FRFausto Roveta
Fausto Roveta
Background: Neurofilament light chain (NfL) is a promising biomarker of neuroaxonal injury, increasingly used to monitor neurodegeneration in Alzheimer’s disease (AD). Multiple analytical platforms are available for NfL quantification in cerebrospinal fluid (CSF), but data on cross-platform consistency remain limited. Objective: This pilot study aimed to provide CSF NfL concentrations measured using Simoa and Lumipulse immunoassays in patients with biologically confirmed AD. Methods: Twenty-eight patients with cognitive impairment fulfilling the biological criteria for AD were enrolled. CSF NfL levels were measured using both Simoa and Lumipulse immunoassays. Statistical analyses assessed intra-individual agreement, correlation between platforms, and associations with cognitive status. Results: NfL concentrations measured with Simoa and Lumipulse showed a strong positive correlation between platforms (Spearman’s ρ = 0.965, p < 0.001), demonstrating excellent analytical concordance. Conclusions: In this pilot study, Simoa and Lumipulse yielded strongly correlated CSF NfL measurements, providing initial evidence of cross-platform consistency. However, these findings require confirmation in larger and diverse cohorts before definitive validation.